Fortitude Advisory Group’s Bio-Techne TECH Stock Holding History

Fortitude Advisory Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-44	Closed	-$5K	–	1167
2022 Q1	$5K	Hold	44	–	–	﹤0.01%	1171
2021 Q4	$6K	Buy	+44	New	+$5.39K	﹤0.01%	1159

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Fortitude Advisory Group's TECH Position: Q2 2022 in Review

Fortitude Advisory Group sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 44 shares — an estimated $5K sold.

Fortitude Advisory Group first reported a position in TECH in Q4 2021 and held it in 2 quarters. The position peaked at $6K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

Fortitude Advisory Group reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
Fortitude Advisory Group sold 44 Bio-Techne shares in Q2 2022, an estimated $5K.
Fortitude Advisory Group first reported a position in Bio-Techne in Q4 2021 and held it in 2 quarters.
Fortitude Advisory Group's Bio-Techne position peaked at $6K in Q4 2021.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.